Abstract
The application of nanotechnology to stem cell research and development has made great strides during the last years. Nanotechnology offers a new opportunity for the research and development of stem cells. The mammary gland is a dynamic organ that undergoes extensive morphogenesis during the different stages of embryonic development, puberty, pregnancy, lactation and involution. There are multipotent stem cells that reside in mammary tissue (MaSCs) with the ability to self-renew and even differentiate into all types of mammary cells. To identify, characterize, and differentiate MaSCs, a variety of methods have been used to understand the signal transduction pathways that promote their self-renewal and their cellular fate. In the last decade, stem cell therapy has become a promising and modern topic of scientific research, which has raised great expectations. However, by itself, it presents some problems that have been overcome with the use of nanoparticles (NPs). A triple function has been accomplished: transport of drugs or biomolecules that help in the differentiation and proliferation of stem cells, cell targeting and contrast agents for real-time monitoring and obtaining bioimages for diagnostic and detection systems. The main objective of applying stem cells in conjunction with NPs is to control cellular activity, mainly the regenerative capacity of mammary tissue against diseases such as mastitis or to optimize milk production. In this review, we provide a current overview of the application of nanomaterials on stem cells, specifically bovine stem cells in both the mammary gland and milk, as they are a potential source of cell progenitors with potential characteristics and could be used in potential therapies based on these cells.
Keywords: Stem cells, nanotechnology, bovine mammary stem cells, milk stem cells, nanoparticles, nanomaterials.
Graphical Abstract
Nanoscience & Nanotechnology-Asia
Title:Stem Cells and Nanoparticles in Therapy
Volume: 11 Issue: 5
Author(s): Viteri Marco, Toscano Fernanda, Gavilanes Alex, Torres Arias Marbel and Seqqat Rachid*
Affiliation:
- Departamento de Ciencias de la Vida, Laboratorio de Inmunología y Virología, Universidad de las Fuerzas Armadas ESPE, Av. Gral. Rumiñahui s/n, P.O. Box 171-5-231B, Sangolquí,Ecuador
Keywords: Stem cells, nanotechnology, bovine mammary stem cells, milk stem cells, nanoparticles, nanomaterials.
Abstract: The application of nanotechnology to stem cell research and development has made great strides during the last years. Nanotechnology offers a new opportunity for the research and development of stem cells. The mammary gland is a dynamic organ that undergoes extensive morphogenesis during the different stages of embryonic development, puberty, pregnancy, lactation and involution. There are multipotent stem cells that reside in mammary tissue (MaSCs) with the ability to self-renew and even differentiate into all types of mammary cells. To identify, characterize, and differentiate MaSCs, a variety of methods have been used to understand the signal transduction pathways that promote their self-renewal and their cellular fate. In the last decade, stem cell therapy has become a promising and modern topic of scientific research, which has raised great expectations. However, by itself, it presents some problems that have been overcome with the use of nanoparticles (NPs). A triple function has been accomplished: transport of drugs or biomolecules that help in the differentiation and proliferation of stem cells, cell targeting and contrast agents for real-time monitoring and obtaining bioimages for diagnostic and detection systems. The main objective of applying stem cells in conjunction with NPs is to control cellular activity, mainly the regenerative capacity of mammary tissue against diseases such as mastitis or to optimize milk production. In this review, we provide a current overview of the application of nanomaterials on stem cells, specifically bovine stem cells in both the mammary gland and milk, as they are a potential source of cell progenitors with potential characteristics and could be used in potential therapies based on these cells.
Export Options
About this article
Cite this article as:
Marco Viteri , Fernanda Toscano , Alex Gavilanes, Marbel Arias Torres and Rachid Seqqat *, Stem Cells and Nanoparticles in Therapy, Nanoscience & Nanotechnology-Asia 2021; 11 (5) : e010121189823 . https://dx.doi.org/10.2174/2210681210999210101155808
DOI https://dx.doi.org/10.2174/2210681210999210101155808 |
Print ISSN 2210-6812 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6820 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
4-Methylumbelliferones Analogues as Anticancer Agents: Synthesis and in Cell Pharmacological Studies
Anti-Cancer Agents in Medicinal Chemistry Nuclear Magnetic Resonance Spectroscopy of Lipids in Cancer
Current Organic Chemistry The Indolylcoumarin COUFIN Exhibits Potent Activity Against Renal Carcinoma Cells without Affecting Hematopoietic System
Anti-Cancer Agents in Medicinal Chemistry Potential Role of <i>In Vitro-In Vivo</i> Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs
Current Drug Targets Palliative Tumor Control by Trabectedin in Pediatric Advanced Sarcoma
Current Drug Therapy Function of miRNA in Controlling Drug Resistance of Human Cancers
Current Drug Targets The Immunoregulatory Protein Human B7H3 is a Tumor-Associated Antigen that Regulates Tumor Cell Migration and Invasion
Current Cancer Drug Targets Co-opting Functions of Cholinesterases in Neural, Limb and Stem Cell Development
Protein & Peptide Letters Vitamin D - Pivotal Nutraceutical in the Regulation of Cancer Metastasis and Angiogenesis
Current Medicinal Chemistry Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies In Vitro Inhibitory Effect of Recombinant Human Calprotectin on Nalm6 Leukemia Cell Line
Anti-Cancer Agents in Medicinal Chemistry Targeting MDM2 and MDMX in Retinoblastoma
Current Cancer Drug Targets Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
Current Protein & Peptide Science Dimer and Tetramer of Gallic Acid: Facile Synthesis, Antioxidant and Antiproliferative Activities
Letters in Drug Design & Discovery The Potential of Flavonoids and Tannins from Medicinal Plants as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Serum miRNAs Signature Plays an Important Role in Keloid Disease
Current Molecular Medicine How Much is Enough? Modulation of Dose-Response Curve for Steroid Receptor-Regulated Gene Expression by Changing Concentrations of Transcription Factor
Current Topics in Medicinal Chemistry NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and Perspectives
Current Drug Targets Chimeric Antigen Receptor T Cells: Self-Replicating Drugs for Cancer
Current Drug Targets Cinnamic Acid Derivatives as Anticancer Agents-A Review
Current Medicinal Chemistry